German Health Review
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Germany

German Health Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Health Review.

Press releases published on June 10, 2025

Prapela’s FDA-Authorized Groundbreaking Therapy for Opioid-Exposed Infants Highlighted at Washington DC Showcase Event

Prapela’s FDA-Authorized Groundbreaking Therapy for Opioid-Exposed Infants Highlighted at Washington DC Showcase Event

Prapela, Inc. joins America's leading MedTech corporations at AdvaMed’s prestigious Capitol Hill event. PORTLAND, ME, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Across the country, hospitals face the continuing challenge of caring for the more …

Turning Uncertainty into Opportunity: VEXOS Opens Second Vietnam Office

Turning Uncertainty into Opportunity: VEXOS Opens Second Vietnam Office

HANOI, VIETNAM, June 10, 2025 /⁨EINPresswire.com⁩/ -- Vexos today announced the opening of its second office in Vietnam, located in Hanoi as part of its ongoing commitment to expand its Custom Material Solutions (CMS) business, and enhance global sourcing …

LinkShadow Unveils CyberMeshX Platform: Ushering in the Next Era of Cybersecurity

LinkShadow Unveils CyberMeshX Platform: Ushering in the Next Era of Cybersecurity

LinkShadow unveils its groundbreaking CyberMeshX Platform, transitioning from siloed security to a comprehensive, mesh-driven cybersecurity ecosystem. ATHENS, GA, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- LinkShadow, a global leader in cutting- …

Graphy Clears Preliminary Review for KOSDAQ Tech IPO — Poised to Redefine Global Digital Orthodontics

Graphy Clears Preliminary Review for KOSDAQ Tech IPO — Poised to Redefine Global Digital Orthodontics

Targeting IPO in August 2025, backed by strong investor confidence and expectations for explosive global growth MIAMI, FL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Graphy Clears Preliminary Review for KOSDAQ Tech IPO — Poised to Redefine …

Daradia’s Web-Based MSK Ultrasound Simulator Pioneers a New Era in Pain Medicine Training Across Europe and Beyond

Daradia’s Web-Based MSK Ultrasound Simulator Pioneers a New Era in Pain Medicine Training Across Europe and Beyond

Cadaver-Free, Accessible Learning Empowers Physicians to Refine Ultrasound-Guided Skills KOLKATA, WEST BENGAL, INDIA, June 10, 2025 /⁨EINPresswire.com⁩/ -- In a bold step towards democratising medical education, Daradia: The Pain Clinic, a globally …

Graphy Clears Preliminary Review for KOSDAQ Tech IPO — Poised to Redefine Global Digital Orthodontics

Graphy Clears Preliminary Review for KOSDAQ Tech IPO — Poised to Redefine Global Digital Orthodontics

Targeting IPO in August 2025, backed by strong investor confidence and expectations for explosive global growth MIAMI, FL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Graphy Clears Preliminary Review for KOSDAQ Tech IPO — Poised to Redefine …

Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs

Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs

A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care for dogs Ingelheim, Germany, and San Francisco, Calif., June 10, 2025 | Boehringer Ingelheim, a global …

XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology

XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology

Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and Commercialization Agreement with Grifols, a global …

HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration

HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration

Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in their Phase Ib clinical trial of its …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service